National Bank of Canada
IRD

National Bank of Canada’s Opus Genetics IRD Stock Holding History

National Bank of Canada’s Portfolio IRD Stock Details IRD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$9.14K Hold
2,014
– – ﹤0.01% 2360
2025
Q4 		$4.03K Hold
2,014
– – ﹤0.01% 2471
2025
Q3 		$3.3K Hold
2,014
– – ﹤0.01% 2521
2025
Q2 		$1.88K Hold
2,014
– – ﹤0.01% 2627
2025
Q1 		$1.91K Hold
2,014
– – ﹤0.01% 2510
2024
Q4 		$2.4K Hold
2,014
– – ﹤0.01% 2559
2024
Q3 		$2.64K Sell
2,014
-9,986
-83% -$15.4K ﹤0.01% 2323
2024
Q2 		$19K Buy
12,000
+10,000
+500% +$17.3K ﹤0.01% 1981
2024
Q1 		$3.42K Hold
2,000
– – ﹤0.01% 2382
2023
Q4 		$6.12K Hold
2,000
– – ﹤0.01% 2258
2023
Q3 		$7.26K Hold
2,000
– – ﹤0.01% 2276
2023
Q2 		$8.68K Hold
2,000
– – ﹤0.01% 2229
2023
Q1 		$7.5K Buy
+2,000
New +$7.18K ﹤0.01% 2213

Other funds holding IRD

CP
Caligan Partners New York $1.5B AUM 518.95% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
BCM
BIOS Capital Management Fort Worth, Texas $52.9M AUM 30.51% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
BCM
Boxer Capital Management San Diego, California $762M AUM 1,125.36% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

National Bank of Canada's IRD Position: Q1 2026 in Review

National Bank of Canada held its Opus Genetics (IRD) position steady in Q1 2026 at 2,014 shares worth $9.14K. The position accounts for ﹤0.01% of the portfolio, ranked #2360.

National Bank of Canada first reported a position in IRD in Q1 2023 and has held it in 13 quarters since. The position peaked at $19K in Q2 2024. 79 funds tracked by Wall St. Rank hold IRD as of Q1 2026.

  • National Bank of Canada held 2,014 shares of Opus Genetics worth $9.14K as of Q1 2026.
  • National Bank of Canada left its Opus Genetics share count unchanged in Q1 2026.
  • Opus Genetics made up ﹤0.01% of National Bank of Canada's portfolio in Q1 2026, its #2360 holding.
  • National Bank of Canada first reported a position in Opus Genetics in Q1 2023 and has held it in 13 quarters since.
  • National Bank of Canada's Opus Genetics position peaked at $19K in Q2 2024.
  • 79 funds tracked by Wall St. Rank held Opus Genetics as of Q1 2026.

Based on National Bank of Canada's 13F filing for Q1 2026, filed 15 May 2026.